164 related articles for article (PubMed ID: 36944283)
1. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
Panou V; Gadiraju M; Wolin A; Weipert CM; Skarda E; Husain AN; Patel JD; Rose B; Zhang SR; Weatherly M; Nelakuditi V; Knight Johnson A; Helgeson M; Fischer D; Desai A; Sulai N; Ritterhouse L; Røe OD; Turaga KK; Huo D; Segal J; Kadri S; Li Z; Kindler HL; Churpek JE
J Clin Oncol; 2018 Oct; 36(28):2863-2871. PubMed ID: 30113886
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL
Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment.
Sculco M; La Vecchia M; Aspesi A; Pinton G; Clavenna MG; Casalone E; Allione A; Grosso F; Libener R; Muzio A; Rena O; Baietto G; Parini S; Boldorini R; Giachino D; Papotti M; Scagliotti GV; Migliore E; Mirabelli D; Moro L; Magnani C; Ferrante D; Matullo G; Dianzani I
Eur J Cancer; 2022 Mar; 163():44-54. PubMed ID: 35032816
[TBL] [Abstract][Full Text] [Related]
7. Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
Poliani L; Greco L; Barile M; Dal Buono A; Bianchi P; Basso G; Giatti V; Genuardi M; Malesci A; Laghi L;
ESMO Open; 2022 Dec; 7(6):100607. PubMed ID: 36356413
[TBL] [Abstract][Full Text] [Related]
8. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
[TBL] [Abstract][Full Text] [Related]
9. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
10. Family Matters: Germline Testing in Thoracic Cancers.
Hathaway F; Martins R; Sorscher S; Bzura A; Dudbridge F; Fennell DA
Am Soc Clin Oncol Educ Book; 2023 May; 43():e389956. PubMed ID: 37167572
[TBL] [Abstract][Full Text] [Related]
11. Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.
Cheung M; Kadariya Y; Sementino E; Hall MJ; Cozzi I; Ascoli V; Ohar JA; Testa JR
Hum Mol Genet; 2021 Aug; 30(18):1750-1761. PubMed ID: 34008015
[TBL] [Abstract][Full Text] [Related]
12. Puzzling Results from
Rizzardi C; Athanasakis E; Cammisuli F; Monego SD; DE Spelorzi YCC; Costantinides F; Giudici F; Pinamonti M; Canzonieri V; Melato M; Pascolo L
Anticancer Res; 2017 Jun; 37(6):3073-3083. PubMed ID: 28551647
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
[TBL] [Abstract][Full Text] [Related]
14. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
[TBL] [Abstract][Full Text] [Related]
15. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR
Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535
[TBL] [Abstract][Full Text] [Related]
16. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
[TBL] [Abstract][Full Text] [Related]
17. Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas.
Guo R; DuBoff M; Jayakumaran G; Kris MG; Ladanyi M; Robson ME; Mandelker D; Zauderer MG
J Thorac Oncol; 2020 Apr; 15(4):655-660. PubMed ID: 31887429
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations and age at onset of lung adenocarcinoma.
Reckamp KL; Behrendt CE; Slavin TP; Gray SW; Castillo DK; Koczywas M; Cristea MC; Babski KM; Stearns D; Marcum CA; Rodriguez YP; Hass AJ; Vecchio MM; Mora P; Cervantes AE; Sand SR; Mejia RM; Tsou TC; Salgia R; Weitzel JN
Cancer; 2021 Aug; 127(15):2801-2806. PubMed ID: 33858029
[TBL] [Abstract][Full Text] [Related]
19. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
Betti M; Casalone E; Ferrante D; Romanelli A; Grosso F; Guarrera S; Righi L; Vatrano S; Pelosi G; Libener R; Mirabelli D; Boldorini R; Casadio C; Papotti M; Matullo G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2015 Jan; 54(1):51-62. PubMed ID: 25231345
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition for malignant mesothelioma: A concise review.
Betti M; Aspesi A; Sculco M; Matullo G; Magnani C; Dianzani I
Mutat Res Rev Mutat Res; 2019; 781():1-10. PubMed ID: 31416570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]